Access to medicines
Landmark ‘TRIPS Waiver’ must be agreed now: no time to lose
Press Release
23 Feb 2022
Too often we cannot treat patients because the medicines are too expensive, or they are no longer produced. Sometimes, the only drugs we have are highly toxic or ineffective and nobody is looking for a better cure.
As a medical humanitarian organisation, it is fundamentally unacceptable that access to essential medicines is increasingly difficult, particularly for the most common global infectious diseases.